Aprocitentan: Dual endothelin eta/etb receptor antagonist treatment of resistant hypertension

B. A. Warden, P. B. Duell

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Aprocitentan: Dual endothelin eta/etb receptor antagonist treatment of resistant hypertension'. Together they form a unique fingerprint.

Medicine & Life Sciences